Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Burkhardt

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Translational Pediatrics|February 3, 2016
Editorial on the role of "Genetic mediators of neurocognitive outcome in survivors of childhood acute lymphoblastic leukemia"Birgit Burkhardt
British Journal of Haematology|December 8, 2009
Paediatric lymphoblastic T-cell leukaemia and lymphoma: one or two diseases?Birgit Burkhardt
Hematological Oncology|June 11, 2015
XI. Management of paediatric and adult non-Hodgkin lymphoma: what lessons can each teach the other?Birgit Burkhardt, Georg Lenz
Pediatric Hematology and Oncology|April 30, 2013
Lymphoblastic lymphoma in childhood and adolescenceEva Schmidt, Birgit Burkhardt
Current Hematologic Malignancy Reports|July 2, 2013
Treatment of adolescents with aggressive B-cell malignancies: the pediatric experienceJonas Lange, Birgit Burkhardt
British Journal of Haematology|February 28, 2019
Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunitiesBirgit Burkhardt, Michelle L Hermiston
Pediatric Blood & Cancer|December 23, 2025
What to Do When Medical Evidence Can Only Be Generated Through Routine Data: An Example From Pediatric OncologyBirgit Burkhardt, Antje Walz, Dietrich Knoerzer
Expert Review of Hematology|December 13, 2016
Mature aggressive B-cell lymphoma across age groups - molecular advances and therapeutic implicationsJonas Lange, Georg Lenz, Birgit Burkhardt
Pediatric Hematology and Oncology|April 11, 2013
Mature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectivesJennifer Worch, Marius Rohde, Birgit Burkhardt
Cancers|February 3, 2015
Immunreconstitution and infectious complications after rituximab treatment in children and adolescents: what do we know and what can we learn from adults?Jennifer Worch, Olga Makarova, Birgit Burkhardt
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Translational Pediatrics|February 3, 2016
Editorial on the role of "Genetic mediators of neurocognitive outcome in survivors of childhood acute lymphoblastic leukemia"Birgit Burkhardt
British Journal of Haematology|December 8, 2009
Paediatric lymphoblastic T-cell leukaemia and lymphoma: one or two diseases?Birgit Burkhardt
Hematological Oncology|June 11, 2015
XI. Management of paediatric and adult non-Hodgkin lymphoma: what lessons can each teach the other?Birgit Burkhardt, Georg Lenz
Pediatric Hematology and Oncology|April 30, 2013
Lymphoblastic lymphoma in childhood and adolescenceEva Schmidt, Birgit Burkhardt
Current Hematologic Malignancy Reports|July 2, 2013
Treatment of adolescents with aggressive B-cell malignancies: the pediatric experienceJonas Lange, Birgit Burkhardt
British Journal of Haematology|February 28, 2019
Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunitiesBirgit Burkhardt, Michelle L Hermiston
Pediatric Blood & Cancer|December 23, 2025
What to Do When Medical Evidence Can Only Be Generated Through Routine Data: An Example From Pediatric OncologyBirgit Burkhardt, Antje Walz, Dietrich Knoerzer
Expert Review of Hematology|December 13, 2016
Mature aggressive B-cell lymphoma across age groups - molecular advances and therapeutic implicationsJonas Lange, Georg Lenz, Birgit Burkhardt
Pediatric Hematology and Oncology|April 11, 2013
Mature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectivesJennifer Worch, Marius Rohde, Birgit Burkhardt
Cancers|February 3, 2015
Immunreconstitution and infectious complications after rituximab treatment in children and adolescents: what do we know and what can we learn from adults?Jennifer Worch, Olga Makarova, Birgit Burkhardt
Pageof 14